Literature DB >> 23602895

Three decades of clinical-pathological trends in gastric cancer: prospective data from a Portuguese hospital.

Gil R Faria1, João Pinto-de-Sousa, John R Preto, Hugo S Sousa, José A Barbosa, José Costa-Maia.   

Abstract

INTRODUCTION: Gastric cancer is a heterogeneous disease, whose pathological and clinical patterns have changed in the last decades. In most western countries, decreases in incidence and mortality and a proximal migration have been reported. The clinical and pathological trends in an European country with high prevalence of gastric cancer were reviewed, based on the patients treated at a University Hospital.
METHODS: Analysis of a prospective database with 1618 patients who underwent surgery for gastric cancer in the last 3 decades. The patients were divided in 3 groups according to decades and the cohorts were analyzed according to demographic, surgical and pathological factors.
RESULTS: The mean age increased from 59.8 to 65.6 years. Antral tumors and intestinal cancer were the most frequent. The rate of complete resection increased as well as the percentage of total gastrectomies and D2-type lymphadenectomies. There was an increase both in early stage carcinomas and in surgically treated Stage-IV carcinomas. The median overall crude survival almost doubled from 14 to 22 months (p = 0.003), but once stratified for stage, only in stage II patients could we observe a significant increase in survival time. (29-47 months; p = 0.047).
CONCLUSION: The proximal migration described for Western Europe was not observed and the intestinal-type carcinoma is still the most frequent. We are treating older patients, often with more advanced disease. In spite of an increasing surgical aggressiveness, the prognosis has only been significantly improved in Stage-II cancers. The prognosis for advanced cancer is still dismal, hence the need for effective adjuvant treatments.
Copyright © 2013 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23602895     DOI: 10.1016/j.ijsu.2013.04.004

Source DB:  PubMed          Journal:  Int J Surg        ISSN: 1743-9159            Impact factor:   6.071


  2 in total

Review 1.  Treatment of early gastric cancer in the Western World.

Authors:  Elfriede Bollschweiler; Felix Berlth; Christoph Baltin; Stefan Mönig; Arnulf H Hölscher
Journal:  World J Gastroenterol       Date:  2014-05-21       Impact factor: 5.742

2.  Early relapses after adjuvant chemotherapy suggests primary chemoresistance in diffuse gastric cancer.

Authors:  Sharon Pattison; Catherine Mitchell; Stephen Lade; Trevor Leong; Rita A Busuttil; Alex Boussioutas
Journal:  PLoS One       Date:  2017-09-18       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.